Skip to main content

HTRF Human IFNγ Detection Kit, 500 Assay Points

The HTRF human IFN gamma kit is designed for the quantification of human IFN gamma release in cell supernatant.

For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption & disposal requirements under European REACH regulations (EC 1907/2006).
Part Number: 62HIFNGPET
Unit Size:
Part Number: 62HIFNGPEG
Unit Size:
Part Number: 62HIFNGPEH
Unit Size:
  • IFN gamma is a pro-inflammatory cytokine secreted by T and NK cells in response to viral infection and or inflammatory conditions. IFN gamma plays a major role in innate and adaptive immunity by promoting T cell differentiation into TH1 and development of Treg, as well as by inhibiting T cell differentiation into TH17. Its anti-tumor properties have been used in treatment of osteoporosis and it is of great interest in immuno-oncology where it improves survival in patients with bladder or ovarian carcinoma.

    Assessment of serum samples often requires enhanced sensitivity. In some cases, AlphaLISA assays may have sufficient sensitivity to enable detection of low levels of analytes in serum or plasma.

  • Assay Points
    Assay Target Type
    Assay Technology
    Therapeutic Area
    Oncology & Inflammation
  • Assay principle

    Cell supernatant, sample, or standard is dispensed directly into the assay plate for the detection by HTRF® reagents (384-well low-volume white plate or Cisbio low-volume 96-well plate in 20 µl). The antibodies labeled with the HTRF donor and acceptor are pre-mixed and added in a single dispensing step, to further streamline the assay procedure. The assay can be run up to a 1536-well format by simply resizing each addition volume proportionally.

    IFN gamma kit assay principle
    Assay data analysis

    The 4 Parameter Logistic (4PL) curve is commonly recommended for fitting an ELISA standard curve. This regression enables the accurate measurement of an unknown sample across a wider range of concentrations than linear analysis, making it ideally suited to the analysis of biological systems like cytokine releases.

  • Technical specifications of human IFN gamma kit
    Sample size 16 µL
    Final assay volume 20 µL
    Kit components Lyophilized standard, frozen detection antibodies, buffers &protocol.
    LOD &LOQ (in Diluent) 14 pg/mL &21 pg/mL
    Range 21 – 4,000 pg/mL
    Time to result Overnight at RT
    Calibration NIBSC (82/587) value (IU/mL) = 0,019 x HTRF hIFN? value (pg/mL)
    Species Human only


  • Intra and inter assay

    Intra-assay (n=24)

    Sample Mean [IFN?] (pg/mL) CV
    1 209 9%
    2 835 11%
    3 4367 7%
      Mean CV 9%

    Each of the 3 samples was measured 24 times, and % CV was calculated for each sample.

    Inter-assay (n=4)

    Sample [IFNg] (pg/mL) Mean (delta R) CV
    1 98 178 14%
    2 432 788 9%
    3 1905 3170 6%
        Mean CV 9.7%

    Each of the samples was measured in 4 different experiments, and % CV was calculated for each sample.

    Dilutional linearity

    ​The excellent % of recovery obtained from these experiments show the good linearity of the assay.​

    Dilution factor [IFNg] expected (pg/mL) [IFNg] detected (pg/mL) Recovery
    1 1 - 150 -
    2.1 72.6 66 91%  
    4.3 35 30 86%  
    Mean 88%      
    2 1 - 1953 -
    2.1 942 959 102%  
    4.3 454 450 99%  
    Mean 100%      


    Spike and recovery
    Sample [IFNg] added (pg/mL) [IFNg] expected (pg/mL) [IFNg] detected (pg/mL) Recovery
    1 2,000 2,421 2,086 86%
    2 2,000 3,360 3,363 100%

    The same amount of recombinant cytokine was added to 2 different serum samples, and the set of responses obtained from a standard curve was compared to the calculated expected values. The ~ 100% of recovery observed validates the sample matrix used for this assay.

  • IFNg secretion in PBMCs stimulated with PMA and Ionomycin

    PBMC plated at 50, 100, 200 and 400 kcells/well were stimulated for 3h with increasing concentrations of PMA (0, 1, 50 ng/mL) added to a 500 ng/mL Ionomycin solution. 16 µL of supernatants were then transferred into a white detection plate (384, low volume) to be analyzed with the Human IFN? Assay.

    IFN? secretion in PBMCs stimulated with PMA and Ionomycin



1-2 of 2 Resources
HTRF solutions, guide to major applications
htrf, guide, application, autoimmunity, cardiology, assays
Reagent solutions for autoimmunity research.
alphalisa, alpha, htrf, surefire, autoimmunity, flyer